Stock MPSYF MORPHOSYS AG
Add to a list
To use this feature you must be a member
Log inSign up

All News MorphoSys AG OTC Markets

Equities

MPSYF

DE0006632003

Market Closed - OTC Markets
Other stock markets
 07:00:02 21/06/2024 pm IST 		5-day change 1st Jan Change
72.38 USD +1.40% Intraday chart for MorphoSys AG +1.40% +76.54%
10/06 MorphoSys AG(XTRA:MOR) dropped from S&P Global BMI Index CI
06/06 MorphoSys AG Announces Board Changes CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
InnoCare Announces the Acceptance of Biologics License Application for Tafasitamab in Combination with Lenalidomide for the treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Adult Patients
AQ
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15
DP
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
BU
Novartis: towards the filing of a buyout offer for MorphoSys
CF
MorphoSys Set to Delist Following Acquisition by Novartis
MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis
MT
Biotech company Morphosys will soon disappear from the stock exchange
RE
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
BU
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
EQ
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
EQ
Deutsche Borse-Unscheduled component changes in MDAX and TecDAX
AQ
MorphoSys to Leave Deutsche Börse’s MDAX, TecDAX Indices
MT
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG(XTRA:MOR) dropped from S&P Global BMI Index
CI
Ad hoc, Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO
AQ
MorphoSys AG Announces Board Changes
CI
MorphoSys AG Appoints Arkadius Pichota as Chief Executive Officer
CI
MorphoSys AG Appoints Lukas Gilgen as CFO
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOR Stock
  4. MPSYF Stock
  5. News MorphoSys AG